Aim: To develop guidelines for clopidogrel prescribing and survey its use to ascertain the need for changes in prescribing patterns. Method: Guidelines were developed after a literature review. Prescribing patterns were assessed by a cross sectional survey which investigated the therapy of inpatients identified taking clopidogrel at a teaching hospital over a 2-month period. Measures of concordance were indications for clopidogrel, contraindications to NSAIDs, timing and range of clopidogrel dosage and associated use of aspirin. Results: Data were collected from 69 patients. 29 (42%) were taking clopidogrel for secondary prevention of ischaemic heart disease - 14 for appropriate indications. 23 (33%) were given clopidogrel before and/or fol...
Ticagrelor is known to prefer clopidigrel except in cases of high risk of bleeding, but according to...
Background/Aims: Antiplatelet therapy with aspirin and clopidogrel is an important component of the ...
Background: Antiplatelet therapy prescribed in combination has been in practice all over the globe. ...
Background: Clopidogrel is used for the secondary prevention of cerebrovascular and cardiovascular e...
noThe National Audit Office (NAO) has produced prescribing indicators that Primary Care Trusts (PCTs...
Background The National Audit Office (NAO) has produced prescribing indicators that Primary Care Tru...
The antiplatelet clopidogrel and the proton pump inhibitor esomeprazole demonstrate a pharmacokineti...
Background: Clopidogrel is an antiplatelet drug increasingly used in the secondary prevention of ath...
<b><i>Background:</i></b> Clopidogrel use as single antiplatelet therapy (SAPT) has never been evalu...
OBJECTIVES: To review systematically the clinical effectiveness and the cost-effectiveness of clopid...
Background/Aims:Antiplatelet therapy with aspirin and clopidogrel is an important component of the m...
Background: Antiplatelet therapy prescribed in combination has been in practice all over the globe. ...
Background: The optimal aspirin dose for the prevention of cardiovascular events remains controversi...
Background/Aims: Antiplatelet therapy with aspirin and clopidogrel is an important component of the ...
QUESTIONS UNDER STUDY: To determine the perception of primary care physicians regarding the risk of ...
Ticagrelor is known to prefer clopidigrel except in cases of high risk of bleeding, but according to...
Background/Aims: Antiplatelet therapy with aspirin and clopidogrel is an important component of the ...
Background: Antiplatelet therapy prescribed in combination has been in practice all over the globe. ...
Background: Clopidogrel is used for the secondary prevention of cerebrovascular and cardiovascular e...
noThe National Audit Office (NAO) has produced prescribing indicators that Primary Care Trusts (PCTs...
Background The National Audit Office (NAO) has produced prescribing indicators that Primary Care Tru...
The antiplatelet clopidogrel and the proton pump inhibitor esomeprazole demonstrate a pharmacokineti...
Background: Clopidogrel is an antiplatelet drug increasingly used in the secondary prevention of ath...
<b><i>Background:</i></b> Clopidogrel use as single antiplatelet therapy (SAPT) has never been evalu...
OBJECTIVES: To review systematically the clinical effectiveness and the cost-effectiveness of clopid...
Background/Aims:Antiplatelet therapy with aspirin and clopidogrel is an important component of the m...
Background: Antiplatelet therapy prescribed in combination has been in practice all over the globe. ...
Background: The optimal aspirin dose for the prevention of cardiovascular events remains controversi...
Background/Aims: Antiplatelet therapy with aspirin and clopidogrel is an important component of the ...
QUESTIONS UNDER STUDY: To determine the perception of primary care physicians regarding the risk of ...
Ticagrelor is known to prefer clopidigrel except in cases of high risk of bleeding, but according to...
Background/Aims: Antiplatelet therapy with aspirin and clopidogrel is an important component of the ...
Background: Antiplatelet therapy prescribed in combination has been in practice all over the globe. ...